Package 55910-249-29

{"route": ["ORAL"], "spl_id": "dba55753-8bbc-4266-b11c-b252efc2e12c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0010002001509"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["955484a6-2a7a-4b15-a9b4-e888ed5de04c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["DOLGENCORP, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 TABLET in 1 BOTTLE, PLASTIC (55910-249-29)", "package_ndc": "55910-249-29", "marketing_start_date": "19930804"}], "brand_name": "Aspirin", "product_id": "55910-249_dba55753-8bbc-4266-b11c-b252efc2e12c", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "55910-249", "generic_name": "Aspirin", "labeler_name": "DOLGENCORP, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "19930804", "listing_expiration_date": "20261231"}